How hospital global budgets affect costs and quality of chemotherapy for adults with cancer
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
This work looks at whether limits on hospital revenue change costs, quality, and use of care for adults with cancer who receive chemotherapy.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11159617 on NIH RePORTER |
What this research studies
If you are an adult receiving chemotherapy, this research compares care and costs before and after Maryland's hospital global budget program and against similar areas without the program using hospital and insurance records. The team will examine hospital stays, complications, readmissions, and receipt of cancer treatments to see if the payment limits changed access or quality. They will use statistical comparisons over time to separate the effect of the budget policy from other trends. The goal is to show whether the policy helped, harmed, or left care unchanged for people like you.
Who could benefit from this research
Good fit: Adults (21+) with cancer who receive chemotherapy and whose care appears in hospital or insurance records from Maryland or comparison regions are the focus of the analysis.
Not a fit: Children, people without cancer, patients not receiving chemotherapy, or those treated outside the included hospitals or states are unlikely to be represented or benefit directly from this study.
Why it matters
Potential benefit: If successful, the findings could guide policymakers to protect access to effective cancer treatments while controlling costs.
How similar studies have performed: Previous evaluations found Maryland's global budget program reduced overall Medicare spending and some hospital readmissions, but its specific effects on cancer care have not been well shown.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Offodile, Anaeze C — Sloan-Kettering Inst Can Research
- Study coordinator: Offodile, Anaeze C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.